1. 934OAlienor/ENGOT-ov7 randomized trial exploring weekly paclitaxel (wP) + bevacizumab (bev) vs wP alone for patients with ovarian sex cord tumors (SCT) in relapse. (23rd October 2018) Authors: Ray-Coquard, I L; Harter, P; Lorusso, D; Dalban, C; Vergote, I B; Fujiwara, K; Gladieff, L; Lueck, H-J; Floquet, A; Lesoin, A F; Schnelzer, A; Pignata, S; Selle, F; Sehouli, J; Brocard, F; Mangili, G; Pautier, P; De Giorgi, U; Provansal, M; Heudel, P-E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP1225 How the conformity of surgical practice with the national guidelines improved the quality of management of ovarian granulosa cell tumors (GCT)? A TMRG and GINECO group study. (1st November 2019) Authors: Lenck, C; Chopin, N; Gouy, S; Bonsang Kitzis, H; Martinez Gomez, C; Radosevic-Robin, N; Martin, S; Lefeuvre-Plesse, C; Lambaudies, E; Leblanc, E; Guyon, F; Classe, J-M; Ramanah, R; Beurrier, F; Angeles-Fite, M; Pomel, C; Joly, F; De La Motte Rouge, T; Provansal, M; Lesoin, A Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP967 Natural history of patients with BRCA-mutated high grade epithelial ovarian cancer (HGEOC) before the era of PARP inhibitors maintenance in 1st line treatment. (1st November 2019) Authors: Romeo, C; Meeus, P; Rodrigues, M; Leblanc, E; Floquet, A; Pautier, P; Marchal, F; Provansal, M; Campion, L; Causeret, S; Gourgou, S; Ray-Coquard, I; Classe, J-M; Pomel, C; De La Motte Rouge, T; Barranger, E; Savoye, AM; Guillemet, C; Gladieff, L; Petit, T Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗